Skip to main content
. 2020 May 15;319(1):H3–H12. doi: 10.1152/ajpheart.00150.2020

Table 1.

Echocardiographic data for sham, TAC, TAC + T, and sham-treated groups at 3, 4, 5 and 6 wk post-sham/TAC surgery

3 wk Post
4 wk Post
5 wk Post
6 wk Post
Sham TAC TAC + T Sham treated Sham TAC TAC+T Sham treated Sham TAC TAC + T Sham treated Sham TAC TAC + T Sham treated
LV mass, mg 373.0 ± 27.7 606.5 ± 72.0 424.4 ± 70.6 385.0 ± 30.7 419.6 ± 36.5 684.8 ± 98.7 573.7 ± 58.8 385.0 ± 30.7 544.7 ± 30.9 711.8 ± 77.3 735.0 ± 80.4 517.2 ± 42.6 631.6 ± 32.5 1012.0 ± 142.7** 742.0 ± 58.8 561.3 ± 65.0
LVID,d, mm 6.1 ± 0.1 5.5 ± 0.3 5.0 ± 0.2 6.2 ± 0.3 6.3 ± 0.1 6.1 ± 0.3 5.5 ± 0.3 6.2 ± 0.3 6.6 ± 0.2 6.8 ± 0.3 6.4 ± 0.4 6.4 ± 0.2 7.1 ± 0.1 7.7 ± 0.5 7.3 ± 0.2 7.0 ± 0.2
LVID,s, mm 3.8 ± 0.1 3.2 ± 0.3 2.9 ± 0.1 3.8 ± 0.2 3.8 ± 0.1 3.7 ± 0.2 3.3 ± 0.2 3.8 ± 0.2 3.8 ± 0.2 4.9 ± 0.3* 4.0 ± 0.4 3.9 ± 0.2 4.4 ± 0.2 5.7 ± 0.5** 4.5 ± 0.2 4.2 ± 0.1
LVPW,d, mm 1.5 ± 0.1 1.9 ± 0.2 1.9 ± 0.2 1.3 ± 0.1 1.6 ± 0.1 1.9 ± 0.2 2.0 ± 0.2 1.3 ± 0.1 1.6 ± 0.1 2.0 ± 0.1 2.3 ± 0.2 1.6 ± 0.1 1.7 ± 0.1 2.3 ± 0.3* 2.0 ± 0.2 1.6 ± 0.1
IVS,d, mm 1.3 ± 0.1 1.7 ± 0.2 1.7 ± 0.2 1.3 ± 0.1 1.4 ± 0.1 1.8 ± 0.2 1.8 ± 0.1 1.3 ± 0.1 1.5 ± 0.0 1.9 ± 0.2 2.2 ± 0.3 1.5 ± 0.1 1.5 ± 0.0 2.2 ± 0.2* 2.3 ± 0.2* 1.6 ± 0.1
HR, beats/min 471.1 ± 9.3 399.5 ± 28.0 424.6 ± 5.5 467.7 ± 11.0 463.9 ± 6.3 391.3 ± 25.7 441.8 ± 19.0 467.7 ± 11.0 438.6 ± 8.9 322.5 ± 29.0* 346.8 ± 44.3 460.5 ± 11.5 434.0 ± 12.8 325.6 ± 34.5** 365.4 ± 34.7 433.8 ± 15.9
E/A ratio 1.8 ± 0.14 1.75 ± 0.11 1.93 ± 0.24 1.68 ± 0.2 1.78 ± 0.13 1.87 ± 0.2 2.1 ± 0.24 1.68 ± 0.2 1.76 ± 0.07 1.57 ± 0.1 1.7 ± 0.12 1.65 ± 0.11 1.72 ± 0.1 1.97 ± 0.1 2.27 ± 0.4 1.65 ± 0.2
PR interval, s 0.04 ± 0.0 0.03 ± 0.0 0.03 ± 0.0 0.03 ± 0.0 0.03 ± 0.0 0.03 ± 0.0 0.04 ± 0.0 0.03 ± 0.0 0.03 ± 0.0 0.04 ± 0.0* 0.04 ± 0.0 0.03 ± 0.0

Values are means ± SE; n, number of subjects. HR, heart rate; IVS,d, interventricular septal thickness in diastole; LVID,d, left ventribular (LV) internal diameter in diastole; LVID,s LV internal diameter in systole; LVPW,d, LV posterior wall thickness in diastole; TAC, transaortic constriction; TAC + T, TAC + treatment. No. of animals in each group are as follows: sham (n = 8), TAC (n = 6), TAC + T (n = 6), and Sham treated (n = 5). Ratio of early (E) to late (A) mitral inflow (E/A).

*

P < 0.05, sham vs. TAC;

**

P < 0.01, sham vs. TAC;

P < 0.05, untreated TAC vs. TAC + treatment;

P < 0.01, untreated TAC vs TAC + treatment.